Aspergillosis clinical trials at UC Davis

1 in progress, 0 open to eligible people

Olorofim Aspergillus Infection Study
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
Sorry, in progress, not accepting new patients
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
Sacramento, California and other locations

Last updated: January 4, 2026

Olorofim Aspergillus Infection Study